In subgroup analyses based on sample gender, age, nodal metastasis status, and disease stage, the transcription level of YTHDF2 was significantly lower in RCC patients than in healthy individuals (Figure 2). This evidence concerns the gene YTHDF2 and renal cell carcinoma.